Watch Carefully (one)pentobarbital will decrease the level or result of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Keep track of patients by now on buprenorphine subdermal implant who need recently-initiated treatment method with CYP3A4 inducer for signs and indications of